Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & Administrative
Others
Ratios

Bone Biologics (BBLG) Shares Outstanding (Weighted Average) (2016 - 2017)

Bone Biologics (BBLG) has disclosed Shares Outstanding (Weighted Average) for 2 consecutive years, with $3.9 million as the latest value for Q3 2017.

  • On a quarterly basis, Shares Outstanding (Weighted Average) fell 89.99% to $3.9 million in Q3 2017 year-over-year; TTM through Sep 2017 was $3.9 million, a 89.99% decrease, with the full-year FY2016 number at $37.6 million, changed N/A from a year prior.
  • Shares Outstanding (Weighted Average) was $3.9 million for Q3 2017 at Bone Biologics, roughly flat from $3.9 million in the prior quarter.
  • In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $38.8 million in Q3 2016 to a low of $3.9 million in Q2 2017.